A comprehensive map of human B cell development has been created by a team of researchers. Their approach will greatly improve researchers' ability to investigate development in cells of all types, make it possible to identify rare aberrations in development that lead to disease, and ultimately help to guide the next generation of research in regenerative medicine.
Discussing why having these kinds of maps is an important advance, Dr. Pe'er explains, "There are so many diseases that result from malfunctions in the molecular programs that control the development of our cell repertoire and so many rare, yet important, regulatory cell types that we have yet to discover. We can only truly understand what goes wrong in these diseases if we have a complete map of the progression in normal development. Such maps will also act as a compass for regenerative medicine, because it's very difficult to grow something if you don't know how it develops in nature. For the first time, our method makes it possible to build a high-resolution map, at the single cell level, that can guide these kinds of research."
Although conventional dogma characterizes development as a series of discrete steps, cells actually develop in a process of continuous transformation. As a cell matures, the complex and interconnected molecular programs that regulate its activity change gradually. These programs can also differ significantly among cells of similar type, and in many important regulatory cell types, rare aberrations in these programs can have devastating effects. Previously, it was difficult to observe these subtle differences in sufficient detail to distinguish them, but new technologies now offer important new opportunities.
In the research described in the Cell paper, the investigators used an emerging technology called mass cytology, which in a single experiment can measure 44 molecular markers simultaneously in millions of individual cells. This provides a wealth of data that can be used to compare, categorize, and chronologically order cells, and makes it possible to begin identifying the molecular systems responsible for development in much greater detail than was ever before possible.
Taking advantage of this complex single-cell data also required the researchers to develop new mathematical and computational methods for interpreting it. Just as one can represent a physical object in three dimensions — length, width, and height — the Pe'er lab's approach involved thinking of the 44 measurements as a 44-dimensional geometric object. They then developed a new computational algorithm, called Wanderlust, which uses mathematical concepts from a field called graph theory to reduce this high-dimensional data into a simple form that is easier to interpret.
Such a high-dimensional geometry is impossible for us to visualize, and so Wanderlust converts the collection of measurements of important developmental markers in each cell into a single one-dimensional value that corresponds to the cell's place within the chronology of development. To properly put each cell in place, Wanderlust converts the high-dimensional geometry into a graph, where each individual cell is represented as a point that is connected by a line (also called an edge) to other cells that are most similar to it. Cells that are closest within the developmental trajectory appear close together on the graph, while those that are at different developmental stages appear farther away. By including all of the hundreds of thousands of cells that were profiled, this graph does not force cells into categories, but represents a continuous new geometry that captures the entire developmental trajectory.
According to Dr. Pe'er, "For years, mathematics has been used in physics to show that there are very elegant mathematical relationships that define the way the universe is structured. When looked at from the perspective of mathematics, we see that the complexity found in biology is also beautifully structured and patterned. Our body has trillions of cells of countless different types, each type bearing different molecular features and behavior. This complexity expands from a single cell in a carefully regulated process called development. This regulation creates patterns and shapes in the high-dimensional data we measure. By using Wanderlust to analyze these data we can find the pattern and trace the trajectory that cellular development follows."
To test their approach, the researchers studied development in human B cells, a type of cell that is important in the adaptive immune response and is involved in a variety of autoimmune diseases as well as certain types of cancer. Since immune cells continue to develop throughout adult life, even a single sample from one bone marrow contains cells from all stages of B-cell development. Investigators in the Nolan lab used mass cytometry to profile 44 markers in a cohort of approximately 200,000 healthy immune cells that were gathered from one such sample. In each cell they measured cell surface markers that help identify what type of cell it is, as well as markers inside the cell that can reveal what the cell is doing, including markers for signaling, the cell cycle, apoptosis, and genome rearrangement.
Using Wanderlust to analyze the high-dimensional data provided by mass cytometry, the researchers accurately ordered the entire trajectory of 200,000 cells according to their developmental chronology. In a strong indication of its accuracy, Wanderlust captured and correctly ordered all of the primary molecular landmarks known to be present in human B cell development. Wanderlust also pinpointed a number of previously unknown key regulatory signaling checkpoints that are required for human B cell development as well as uncharacterized subtypes of B cell progenitor cells that correspond to important developmental stages. This trajectory constitutes the most comprehensive analysis of human B cell development that has ever been conducted.
In a sign of the high degree of precision that Wanderlust offers for studying single cells, the researchers also report that they identified rare, previously unknown signaling events involving the signaling protein STAT5 that occurred in just 7 out of 10,000 cells. This regulatory event is involved in the process of VDJ recombination, a volatile time when the B-cell is reshuffling its own DNA. Further laboratory experiments showed that disrupting these signaling events using kinase inhibitors fully stalled the development of B cells.
Identifying and characterizing the regulatory checkpoints that control and monitor cell fate can have many practical applications, as many diseases result from imbalance in the cell types produced by the immune system. Thus, the approach that the authors describe can produce insights that could be used for the development of new diagnostics and therapeutics.
This process for mapping how healthy cells develop can be applied not just to B cells, but to any type of cell. As the authors suggest, their method offers the possibility of providing a foundation for studying normal development as well as the processes responsible for any kind of developmental disease. In the future, they anticipate that more sophisticated models could be built that would be capable of representing even more complex systems, such as the entire immune system. The holy grail would involve creating a complete map of every cell type in the body and how each progressively develops from a single stem cell, pinpointing every cell fate decision along the way.
Achieving this goal will require a lot more work, but as Dr. Pe'er points out, "This current project is a landmark both in the study of development and in single-cell research, and has completely changed the way I think about science. A fire has been lit, and these findings are just the tip of the iceberg of what is now possible."